Apotex alleged that particular US court judgments and FDA choices discriminated in opposition to it, denied it least standard of cure and expropriated its financial investment in pravastatin. Damages sought: US£eight million.condition case as a respondent. Nonetheless, US (as well as other) buyers have benefited from NAFTA protections.|29 Once ag